| Home : April 2020 : April 14, 2020 News : Ligandal Is Developing Potential Antidote And Vaccine To SARS-CoV-2 |
Ligandal Is Developing Potential Antidote And Vaccine To SARS-CoV-2 |
April 14, 2020
SAN FRANCISCO, April 14, 2020 /PRNewswire/ -- Biological engineering company Ligandal, Inc. is applying its unique peptide-based delivery technologies to develop a prospective antidote and vaccine for SARS-CoV-2 (the novel coronavirus) to be formulated and developed in response to the...
https://www.prnewswire.com:443/news-releases/ligandal-is-developing-potential-antidote-and-vaccine-to-sars-cov-2-301039844.html
|
|
|
 Other Stories |
|
|
|
|
|
|
|
|
|
|
|
